Denali Therapeutics secures $275 million royalty deal with Royalty Pharma
Go back to Denali Therapeutics secures $275 million royalty deal with Royalty Pharma| (NASDAQ: DNLI) | Delayed: 22.55 -0.71 (3.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.26 | 52 Week High | $ | |||
| Open | $23.33 | 52 Week Low | $ | |||
| Day High | $23.86 | P/E | N/A | |||
| Day Low | $22.53 | EPS | $ | |||
| Volume | 810,185 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 62.49 +0.17 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.32 | 52 Week High | $3.48 | |||
| Open | $62.66 | 52 Week Low | $0.80 | |||
| Day High | $63.29 | P/E | N/A | |||
| Day Low | $62.03 | EPS | $-1.54 | |||
| Volume | 1,239,334 | |||||
